The report on the Hematology Diagnostics Market is segmented By Product (Hematology Instruments, Hematology Consumables), Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit), End-Use (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others), and Region - COVID-19 Impact Analysis and Forecast to 2026. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Market Insights
The Hematology Diagnostics Market is projected to grow from USD 5.9 billion in 2020 to USD 8.3 billion by 2026 at a CAGR of around 5.8% during the forecast period.
Key players
Some of the major players operating in the global Hematology Diagnostics Market are-
Report Features
The report provides critical insights into the market dynamics that enables strategic decision making that is critical to the growth of the existing players as well as those planning to enter the market. This report offers an improvised approach to consolidate the growth decisions by covering the following features –
Market Dynamics
The report covers maximum factors that affect the Hematology Diagnostics Market. According to this report,
The growth of the hematology diagnostics market is primarily driven by rising incidences of blood disorders. Expanding geriatric population is likely to drive the market growth further. Rising awareness among consumers relating to blood disorders is expected to augment the market growth substantially. In addition to this, increasing investment in research and development activities to develop advanced diagnostic solutions is likely to create lucrative opportunities for the players operating in the global hematology diagnostics market in the coming years.
End-Use Trends
By end-use, the hematology diagnostics market has been bifurcated into diagnostic laboratories, hospitals & clinics, academic institutes, and others. The hospitals & clinics segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment can be attributed to the presence of established infrastructure and skilled staff.
Regional Trends
By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to expanding geriatric populace and growing emphasis on the adoption of advanced diagnostic solutions in the healthcare industry coupled with the presence of key market players such as Abbott Laboratories (US) and Beckman Coulter Inc. (US). The market growth in Asia-Pacific is expected to be driven by an increasing number of people having blood disorders.
Critical Questions Answered in the Report
Wish to know more about the study? Click here to get a free sample. https://www.stratviewresearch.com/Request-Sample/2368/Hematology-Diagnostics-Market.html#form
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at +1-313-307-4176.
About Us –
Stratview Research is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. This firm possesses a global presence to enable current market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. It also surveys clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.
Contact -
Web: https://www.stratviewresearch.com/contact
Email: sales@stratviewresearch.co
Hematology diagnostics distributors, Hematology diagnostics suppliers, Hematology diagnostics manufacturers, Logistics organizations, Government bodies are the target audience in the hematology diagnostics market.